These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 205164)

  • 21. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG
    Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dyslipoproteinemias.
    Brown DF
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():18-52. PubMed ID: 4369284
    [No Abstract]   [Full Text] [Related]  

  • 24. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of HDL-cholesterol].
    Reuter W; Herrmann W
    Z Gesamte Inn Med; 1981 Jul; 36(14):473-9. PubMed ID: 6944971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiatherogenic effect of high density lipoprotein].
    Turczyn B; Skoczyńska A
    Postepy Hig Med Dosw; 2002; 56(4):499-520. PubMed ID: 12418415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in coronary artery disease risk-factor research: what remains to be done?
    Crouse JR
    Clin Chem; 1984 Jul; 30(7):1125-7. PubMed ID: 6428775
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-density and high-density lipoprotein subspecies and risk for premature coronary artery disease.
    Brunzell JD; Hokanson JE
    Am J Med; 1999 Aug; 107(2A):16S-18S. PubMed ID: 10484232
    [No Abstract]   [Full Text] [Related]  

  • 30. Another coronary risk factor--HDL cholesterol.
    Sannella JJ
    J Tenn Med Assoc; 1977 May; 70(5):334. PubMed ID: 194113
    [No Abstract]   [Full Text] [Related]  

  • 31. The association of serum lipids, lipoproteins, and apolipoproteins with coronary artery disease assessed by coronary arteriography.
    Naito HK
    Ann N Y Acad Sci; 1985; 454():230-8. PubMed ID: 3865610
    [No Abstract]   [Full Text] [Related]  

  • 32. The lipoproteins: predictors, protectors, and pathogens.
    Lewis B
    Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1161-4. PubMed ID: 6414611
    [No Abstract]   [Full Text] [Related]  

  • 33. The meaning of a new marker for coronary-artery disease.
    Blackburn H
    N Engl J Med; 1983 Aug; 309(7):426-8. PubMed ID: 6410240
    [No Abstract]   [Full Text] [Related]  

  • 34. [Elastolytic activity and free oxyproline in the blood in different types of hyperlipoprotenemia in patients with ischemic heart disease].
    Mikunis RI; Serkova VK
    Ter Arkh; 1977; 49(4):37-40. PubMed ID: 194349
    [No Abstract]   [Full Text] [Related]  

  • 35. Apoproteins B and A-I and coronary artery disease in humans.
    Brunzell JD; Sniderman AD; Albers JJ; Kwiterovich PO
    Arteriosclerosis; 1984; 4(2):79-83. PubMed ID: 6422918
    [No Abstract]   [Full Text] [Related]  

  • 36. Significance of high-density lipoprotein cholesterol.
    Thompson P; Bortz WM
    J Am Geriatr Soc; 1978 Oct; 26(10):440-2. PubMed ID: 212463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein subspecies and risk of coronary disease.
    Musliner TA; Krauss RM
    Clin Chem; 1988; 34(8B):B78-83. PubMed ID: 3042203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood lipids and lipid peroxides in the families of patients with ischemic heart disease].
    Davidenkova EF; Shafran MG; Veksler BM; Magracheva EIa; Lozovskiĭ VT
    Kardiologiia; 1989 Jun; 29(6):10-4. PubMed ID: 2779063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDL and coronary heart disease.
    Lancet; 1980 Nov; 2(8204):1139-40. PubMed ID: 6107751
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipid profiles, alopecia, and coronary disease: any relationship?
    Guzzo CA; Margolis DJ; Johnson J
    Dermatol Surg; 1996 May; 22(5):481. PubMed ID: 8634815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.